# cansinotech

**Canonical:** https://apis.io/providers/cansinotech/  
**Website:** https://cansinotech.com.cn  
**APIs profiled:** 0

CanSino Biologics (康希诺生物, cansinotech.com.cn / cansinotech.com) is a Tianjin-based Chinese biopharmaceutical company founded in 2009 and dual-listed on the Hong Kong and Shanghai (STAR) exchanges. It researches, manufactures, and commercializes human vaccines across five proprietary technology platforms, with a portfolio covering COVID-19, meningococcal, pneumococcal, tuberculosis, Ebola, and DTcP indications. Surfaced as a portfolio company of Qiming Ventures and added to the API Evangelist network. As of this enrichment pass the company publishes no public API, developer portal, SDKs, or technical documentation; only its corporate web presence was found.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Cansinotech Domain Security** — TLSv1.2

## Tags

Company, biopharmaceuticals, Vaccines, Healthcare, Life Sciences, Biotechnology, China

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/cansinotech/). Scores are computed from the provider's own public artifacts under a published rubric.